Authors:
Rosenberg, JJ
Martin, SW
Seely, JE
Kinstler, O
Gaines, GC
Fukuzuka, K
Rose, J
Kohno, T
Boyle, WJ
Nelson, A
Kieft, GL
Marshall, WS
Feige, U
Gasser, J
St Clair, J
Frazier, J
Abouhamze, A
Moldawer, LL
Edwards, CK
Citation: Jj. Rosenberg et al., Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon, J APP PHYSL, 91(5), 2001, pp. 2213-2223
Authors:
Feige, U
Hu, YL
Gasser, J
Campagnuolo, G
Munyakazi, L
Bolon, B
Citation: U. Feige et al., Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats, CELL MOL L, 57(10), 2000, pp. 1457-1470
Authors:
Davis, MW
Feige, U
Bendele, AM
Martin, SW
Edwards, CK
Citation: Mw. Davis et al., Treatment of rheumatoid arthritis with PEGylated recombinant human solubletumour necrosis factor receptor type I: a clinical update, ANN RHEUM D, 59, 2000, pp. 41-43
Authors:
Kong, YY
Feige, U
Sarosi, I
Bolon, B
Tafuri, A
Morony, S
Capparelli, C
Li, J
Elliott, R
McCabe, S
Wong, T
Campagnuolo, G
Moran, E
Bogoch, ER
Van, G
Nguyen, LT
Ohashi, PS
Lacey, DL
Fish, E
Boyle, WJ
Penninger, JM
Citation: Yy. Kong et al., Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, NATURE, 402(6759), 1999, pp. 304-309